Stereotaxis (STXS) News

Stereotaxis (STXS): $2.22

0.13 (+6.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter STXS News Items

STXS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

STXS News Highlights

  • For STXS, its 30 day story count is now at 5.
  • Over the past 18 days, the trend for STXS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about STXS are ST and KE.

Latest STXS News From Around the Web

Below are the latest news stories about Stereotaxis Inc that investors may wish to consider to help them evaluate STXS as an investment opportunity.

Stereotaxis to Present at Upcoming Investor Conferences

ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, chairman and CEO, will present at three investor conferences in the first quarter 2022.

GlobeNewswire | February 14, 2022

Stereotaxis to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2021 fourth quarter and full year ended December 31, 2021 on Thursday, March 3, 2022 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments

Yahoo | February 14, 2022

Roubaix Capital, LLC Buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Sells Rogers ...

Investment company Roubaix Capital, LLC (Current Portfolio) buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Xometry Inc, First Citizens BancShares Inc, sells Rogers Corp, Alliance Data Systems Corp, Hayward Holdings Inc, Gates Industrial Corp PLC, Aspen Aerogels Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Roubaix Capital, LLC.

Yahoo | January 28, 2022

Fuwai Central China Cardiovascular Hospital Becomes First to Offer Advanced Robotic Treatment for Heart Rhythm Disorders in Central China

ST. LOUIS, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Fuwai Central China Cardiovascular Hospital has become the first in central China to establish a robotic electrophysiology program with installation of Stereotaxis’ Robotic Magnetic Navigation technology. Chief physicians for arrhythmia treatment, Dr. Chen Ke and Dr. Song Weifeng, successfully performed their first ro

Yahoo | January 27, 2022

HonorHealth Scottsdale Shea Medical Center Builds Advanced Robotic Program to Treat Heart Rhythm Disorders

ST. LOUIS, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that HonorHealth has established a robotic electrophysiology program as part of its Cardiovascular Center of Excellence at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona. HonorHealth is among the first in the nation to offer the Genesis Robotic Magnetic Navigation (RMN) system to patients receiving minim

Yahoo | January 25, 2022

Morgan Stanley Acquires 305,835 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Morgan Stanley boosted its holdings in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 3,094.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 315,717 shares of the companys stock after acquiring an additional 305,835 shares during the quarter. Morgan Stanleys holdings in Stereotaxis were []

Dakota Financial News | December 13, 2021

Hedge Funds Are Crazy About Stereotaxis Inc (STXS)

No summary available.

Insider Monkey | December 12, 2021

Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication

ST. LOUIS, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS ), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in Frontiers in Cardiovascular Medicine titled "Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism." This multi-center, prospective study evaluated 166 patients with paroxysmal or persistent Atrial Fibrillation (AF) who underwent pulmonary vein isolation using either Stereotaxis'' Robotic Magnetic Navigation (RMN) technology or manual contact force ablation catheters. All patients received cerebral magnetic resonance imaging within 48 hours before and after the ablation procedure to assess cerebral embolism. Patients treated using R...

Benzinga | December 8, 2021

AI-based Surgical Robots: Market Integration of Latest Technologies into Existent Offerings with Key Players | TransEnterix, Mazor Robotics, Stereotaxis, Medrobotics Corp

Qurates most recent research report on AI-based Surgical Robots was performed by extremely qualified research professionals and business experts in order to provide an in-depth assessment on the market. The study on AI-based Surgical Robots is extensive and consist of

OpenPR | December 7, 2021

Zacks Investment Research Lowers Stereotaxis (NYSEAMERICAN:STXS) to Strong Sell

Zacks Investment Research cut shares of Stereotaxis (NYSEAMERICAN:STXS) from a hold rating to a strong sell rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospitals interventional surgical suite to enhance the treatment of coronary artery []

Dakota Financial News | November 21, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5622 seconds.